Illumina shows promising trend. More patience required with Genomic stocks.

Greetings, fellow investors! Welcome back to ShareTreck. I'm Raj, today I am going to share my thoughts around the genomic stocks in our watchlist. It is quite frustrating to see promising technology so undervalued across the board. Patience is needed. Resilience is needed if we were to come out alive on the other side - hopefully in September.

Well this is my personal opinion, not financial advice.

JOIN THE CHANNEL AS A MEMBER:

Please check out the membership offering and join me in the exciting new chapter for ShareTreck, Thanks for your support so far and looking forward to much more. Use the link below to join or click on the Join button on the bottom left of your screen or copy the link below to your browser address bar and press enter.

   / @sharetreck  

Please subscribe:    / @sharetreck  

The videos in this channel should not be construed as financial advice. Always make sure to do your own due diligence and research.
Please do not trade or invest based on this video. Information provided in this video is not investment advice and is for entertainment purposes only.
In case of coverage of pharma companies, disease and therapy details are derived from news articles and publications by companies or research organizations. I am not a doctor but am only facilitating dissemination of published information.